Changqing Zhao

1.3k citations
77 papers · 802 indexed · h-index 16
Topics
Asthma and respiratory diseases (26 papers)Allergic Rhinitis and Sensitization (20 papers)Sinusitis and nasal conditions (8 papers)

In The Last Decade

Changqing Zhao

69 papers receiving 784 citations

Peers

Changqing Zhao
Comparison fields: 5 of 100
  • Physiology 216
  • Pathology and Forensic Medicine 196
  • Immunology and Allergy 183
  • Molecular Biology 169
  • Pharmacology 150
Replace Ted T. Kung with:
Ted T. Kung United States
Yukiko Yagi Japan
David Hollander United States
Rosaria Ilaria Staiano Italy
Dongmin Dang United States
Tetsuya Kawakita Japan
Masaya Harada Japan
Luting Xu United States
Luca Agnifili Italy
Riccardo Sibilano United States
Changqing Zhao relative to Ted T. Kung United States Ted T. Kung's profile →
Citations per field
00.5×6.3×
Ted T. Kung · 1×
Citations per year

Countries citing papers authored by Changqing Zhao

Since Specialization
Citations

This map shows the geographic impact of Changqing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changqing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changqing Zhao more than expected).

Fields of papers citing papers by Changqing Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changqing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changqing Zhao. The network helps show where Changqing Zhao may publish in the future.

Co-authorship network of co-authors of Changqing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Changqing Zhao. A scholar is included among the top collaborators of Changqing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changqing Zhao. Changqing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 2
4 2
5 1
6 6
7 6
8 1
9 1
10 5
11 3
12 19
13 1
14 9
15 26
16 54
17 152
18 2
19 25
20 38

About Changqing Zhao

Changqing Zhao is a scholar working on Immunology and Allergy, Otorhinolaryngology and Physiology, having authored 77 papers that have together received 802 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (26 papers), Allergic Rhinitis and Sensitization (20 papers) and Sinusitis and nasal conditions (8 papers). The work is most often cited by research in Immunology and Allergy (183 citations), Pathology and Forensic Medicine (196 citations) and Pharmacology (150 citations). Changqing Zhao has collaborated with scholars based in China, United States and Slovakia. Frequent co-authors include Li‐Yang Dai, Lei‐Sheng Jiang, Debra F. Skafar, Xiaohong Chen, Yuehui Zhang, Joshua E. Adler, Anne M. Skoff, Janice A. Schwartz, Judith Abrams and Akiko Koide. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026